Moreover, GLP-1RAs have neuroprotective, anti-infectious, cardiovascular protective, and metabolic regulatory effects, exhibiting good application prospects
To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist
Ann Transl Med, 2016
Some HSA/FSA administrators require additional documentation for compounded preparations
Here are some reasons this could be happening: Youve lost weight and need fewer calories: One reason this could be happening is that, as you lose weight, your body needs fewer calories than before, so weight loss naturally slows down
In patients with obesity, weight reduction often leads to improvements in left ventricular mass and diastolic function